As the chill of winter approaches, most of us are well-versed in the annual warnings about the flu and, more recently, ...

A new study reveals that respiratory syncytial virus (RSV) hospitalizations have significantly higher risks for heart ...

Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

Researchers analyzed data from more than 787,000 older adults tested for RSV between October 2023 and April 2024, finding the vaccine equally effective for both 60-74-year-olds and those 75 and older.

This lack of testing amplifies the misdiagnosis of RSV, as its symptoms are so similar to other, more common respiratory viruses like flu. A lack of recognition can also be seen in older adults ...

The World Health Organization (WHO) has published its first ever position paper on immunization against respiratory syncytial ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

"Respiratory viral infections (RVIs) are associated with elevated cardiovascular risk; however, less is known about cardiac ...

In response to the global burden of severe RSV disease among infants, WHO recommends that all countries introduce either the ...

Patients with RSV hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations.

RSV causes about 100,000 deaths and more than 3.6 million hospitalisations in children under the age of 5 worldwide ...

Experts say new immunisation program working, but some babies missing outThe number of Australian babies admitted to hospital ...